Keyphrases
Mitophagy
97%
Leucine-rich Repeat Kinase 2 (LRRK2)
52%
Parkinson's Disease
47%
Parkin
31%
Mitochondria
27%
Mitochondrium
27%
Induced Stem Cell
26%
Proteomic Comparison
26%
Human-induced
26%
Embryonic Stem Cells
26%
Functional Comparison
26%
Induced Pluripotent Stem Cells (iPSCs)
26%
Human Embryo
26%
Human Embryonic Stem Cells (hESCs)
20%
Penetrant
14%
Primary Neurons
14%
Phosphorylation
14%
Skeletal muscle
14%
G2019S Knock-in
13%
Pharmacological Rescue
13%
Target Following
13%
Automated Quantification
13%
Metabolic Programming
13%
Mouse Tissue
13%
LRRK2 Inhibitors
13%
Intestinal Intraepithelial Lymphocytes
13%
Intraepithelial Lymphocytes
13%
Disease-related
13%
Metabolic Demand
13%
Orally Bioavailable
13%
Interleukin-15 (IL-15)
13%
Semi-automated
13%
Degrader
13%
Physiological Function
13%
Ubiquitylation
13%
Blood-brain Barrier
13%
PIM Kinase
13%
Proteolysis Targeting chimera (PROTAC)
13%
Mito-QC
10%
Cytoplasmic Proteins
9%
Mitochondrial Proteins
7%
Disease Modeling
7%
Mitochondrial Depolarization
7%
Autophagy
6%
Protein Phosphorylation
6%
Video Project
6%
Medical Research Council
6%
Audio
6%
Protein Ubiquitylation
6%
IL-15 Receptor
5%
Biochemistry, Genetics and Molecular Biology
Mitophagy
100%
PINK1
53%
LRRK2
39%
Proteomics
28%
Ubiquitination
26%
Induced Stem Cells
26%
Embryonic Stem Cell
26%
Human Induced Pluripotent Stem Cell
26%
Mitochondrion
25%
Kinase
21%
Phosphotransferase
21%
Serine
14%
Skeletal Muscle
14%
Leucine-Rich Repeat
13%
Protein Phosphorylation
13%
Blood Brain Barrier
13%
Intraepithelial Lymphocyte
13%
Interleukin 15
13%
Proteolysis
13%
Disease Modeling
8%
Mitochondrial Protein
8%
Ubiquitin
7%
Neuroscience
Mitophagy
82%
Parkinson's Disease
35%
In Vivo
29%
Parkin
17%
Skeletal Muscle
14%
Leucine Rich Repeat Kinase 2
13%
Proteolysis
13%
Blood Brain Barrier
13%
Mitochondrion
11%
Serine
9%
Kinase
6%
In Vitro
5%